Results 251 to 260 of about 205,089 (292)
Some of the next articles are maybe not open access.
Current Problems in Cancer, 1999
The topic of brain metastases has recently become a popular subject for review. The reasons for this most likely include technical advances in therapy, notably radiosurgery, as well as recently-published reports of phase III studies, which have addressed certain aspects of management, notably the combination of surgery and radiotherapy in the treatment
Harry S Greenberg +2 more
openaire +3 more sources
The topic of brain metastases has recently become a popular subject for review. The reasons for this most likely include technical advances in therapy, notably radiosurgery, as well as recently-published reports of phase III studies, which have addressed certain aspects of management, notably the combination of surgery and radiotherapy in the treatment
Harry S Greenberg +2 more
openaire +3 more sources
Neurologic Clinics, 2018
Brain metastases from solid tumors are associated with increased morbidity and mortality. Standard treatment is local therapy with surgery and/or radiation therapy although there is increasing interest in systemic therapies that can control both intracranial and extracranial disease. We review the most recent data for local therapy and systemic therapy
Ayal A, Aizer, Eudocia Q, Lee
+5 more sources
Brain metastases from solid tumors are associated with increased morbidity and mortality. Standard treatment is local therapy with surgery and/or radiation therapy although there is increasing interest in systemic therapies that can control both intracranial and extracranial disease. We review the most recent data for local therapy and systemic therapy
Ayal A, Aizer, Eudocia Q, Lee
+5 more sources
Current Treatment Options in Neurology, 2008
Metastatic brain tumors are the most common intracranial neoplasm in adults, affecting up to 10% of adults with cancer in the United States. The risk of developing brain metastases varies by primary cancer type, with lung cancer, breast cancer, and melanoma accounting for the majority.
April F, Eichler, Scott R, Plotkin
openaire +2 more sources
Metastatic brain tumors are the most common intracranial neoplasm in adults, affecting up to 10% of adults with cancer in the United States. The risk of developing brain metastases varies by primary cancer type, with lung cancer, breast cancer, and melanoma accounting for the majority.
April F, Eichler, Scott R, Plotkin
openaire +2 more sources
Neurologic Clinics, 2003
Brain metastases are one of the most feared complications of cancer because even small tumors may cause incapacitating neurologic symptoms. This article reviews the epidemiology, clinical features, treatment, and prognosis of brain metastases from system malignancies.
Andrew B, Lassman, Lisa M, DeAngelis
openaire +3 more sources
Brain metastases are one of the most feared complications of cancer because even small tumors may cause incapacitating neurologic symptoms. This article reviews the epidemiology, clinical features, treatment, and prognosis of brain metastases from system malignancies.
Andrew B, Lassman, Lisa M, DeAngelis
openaire +3 more sources
Current Treatment Options in Oncology, 2000
Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients
P Y, Wen, J S, Loeffler
openaire +2 more sources
Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients
P Y, Wen, J S, Loeffler
openaire +2 more sources
Current Treatment Options in Oncology, 2001
Metastatic tumors to the brain are an increasing cause of morbidity and mortality in patients with systemic cancers. Many new therapies used to treat systemic cancers do not penetrate the central nervous system (CNS) and do not protect patients from the development of brain metastases.
M G, Ewend +4 more
openaire +2 more sources
Metastatic tumors to the brain are an increasing cause of morbidity and mortality in patients with systemic cancers. Many new therapies used to treat systemic cancers do not penetrate the central nervous system (CNS) and do not protect patients from the development of brain metastases.
M G, Ewend +4 more
openaire +2 more sources
Neurologic Clinics, 2007
Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy.
Teri D, Nguyen, Lisa M, DeAngelis
openaire +2 more sources
Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy.
Teri D, Nguyen, Lisa M, DeAngelis
openaire +2 more sources
Journal of Neuroimaging, 2011
The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Sasan, Karimi +4 more
openaire +2 more sources
The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Sasan, Karimi +4 more
openaire +2 more sources
Journal of Clinical Oncology, 2006
Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients ...
Michael A, Vogelbaum, John H, Suh
openaire +2 more sources
Brain metastases are the most common brain tumors seen in clinical practice, comprising well over half of all brain tumors. For many years, surgical resection of brain metastases was considered a form of palliative therapy only, but more recently it has been shown to have a more important role in extending survival in appropriately selected patients ...
Michael A, Vogelbaum, John H, Suh
openaire +2 more sources
Neurosurgery Clinics of North America, 1996
Metastases of the brain are the most frequent metastatic neurologic complication of systemic cancer and are second only to metabolic encephalopathies as a cause of central nervous system dysfunction in cancer patients. Despite recent significant advances in the diagnosis and treatment of metastases to the brain, many patients will suffer from ...
E, Alexander, J S, Loeffler
openaire +2 more sources
Metastases of the brain are the most frequent metastatic neurologic complication of systemic cancer and are second only to metabolic encephalopathies as a cause of central nervous system dysfunction in cancer patients. Despite recent significant advances in the diagnosis and treatment of metastases to the brain, many patients will suffer from ...
E, Alexander, J S, Loeffler
openaire +2 more sources